Published in J Clin Endocrinol Metab on July 01, 1982
Acromegaly with 'normal' growth hormone levels. West J Med (1985) 0.75
Recent developments in acromegaly: a review. J R Soc Med (1983) 0.75
Acromegaly update--etiology, diagnosis and management. West J Med (1987) 0.75
Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem (1986) 2.30
Reproductive health under attack at the United Nations. Reprod Health Matters (2001) 1.92
Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res (1991) 1.61
Activation of p34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis. J Biol Chem (1994) 1.53
Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1. Growth Horm IGF Res (2000) 1.47
Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay. J Clin Endocrinol Metab (2001) 1.41
Retention of airborne latex particles by a bacterial and viral filter used in anaesthesia apparatus. Anaesthesia (2001) 1.39
Scanning secondary ion analytical microscopy with parallel detection. Biol Cell (1992) 1.23
A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit. Endocrinology (2000) 1.21
Workplace bullying and sleep disturbances: findings from a large scale cross-sectional survey in the French working population. Sleep (2009) 1.19
Nuclear localization of the testis determining gene product SRY. J Cell Biol (1995) 1.19
Production of insulin-like growth factors and their carrier by rat pituitary gland and brain explants in culture. FEBS Lett (1981) 1.18
Reversible gonadotropin deficiency in male Cushing's disease. J Clin Endocrinol Metab (1977) 1.11
A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology (1996) 1.10
[Cerebral ischemic accidents in young subjects. A prospective study of 296 patients aged 16 to 45 years]. Rev Neurol (Paris) (1999) 1.10
Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology (1995) 1.10
Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest (1990) 1.09
Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man. Eur J Biochem (1987) 1.08
Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly. N Engl J Med (1987) 1.08
"Silent" MRI with soft gradient pulses. Magn Reson Med (1999) 1.08
Criteria for evaluating mucus functions and their disorders in chronic bronchitis. Ciba Found Symp (1978) 1.07
The cramped gene of Drosophila is a member of the Polycomb-group, and interacts with mus209, the gene encoding Proliferating Cell Nuclear Antigen. Development (1997) 1.07
Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf) (1994) 1.05
Circadian rhythms in lung resistance and dynamic lung compliance of healthy children. Effects of two bronchodilators. Respir Physiol (1977) 1.05
The serum response factor nuclear localization signal: general implications for cyclic AMP-dependent protein kinase activity in control of nuclear translocation. Mol Cell Biol (1995) 1.04
Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Endocrinology (1997) 1.04
Genome-wide analysis of Sox genes in Drosophila melanogaster. Mech Dev (2001) 1.04
Late-onset adrenal hyperplasia in hirsutism. N Engl J Med (1985) 1.03
Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab (1990) 1.00
The HIV-1(Lai) RNA dimerization. Thermodynamic parameters associated with the transition from the kissing complex to the extended dimer. Eur J Biochem (2000) 1.00
Scalp nerve blocks decrease the severity of pain after craniotomy. Anesth Analg (2001) 1.00
Production of insulin-like growth factors and their binding proteins by rabbit articular chondrocytes: relationships with cell multiplication. Endocrinology (1989) 0.99
Sox neuro, a new Drosophila Sox gene expressed in the developing central nervous system. Mech Dev (2000) 0.99
Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries. J Clin Invest (1985) 0.98
The energy cost of running increases with the distance covered. Eur J Appl Physiol Occup Physiol (1991) 0.97
Solitary skin metastasis as the presenting feature of differentiated thyroid microcarcinoma: report of two cases. J Endocrinol Invest (1995) 0.97
Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab (1994) 0.97
Allergic bronchopulmonary aspergillosis and omalizumab. Allergy (2011) 0.97
Environmental exposure to cadmium and human birthweight. Toxicology (1993) 0.97
Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab (1989) 0.96
Comparative study of biosynthetic human growth hormone immunogenicity in growth hormone deficient children. Horm Res (1991) 0.96
The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology (1997) 0.95
Identification of an insulin-like growth factor-binding protein in human cerebrospinal fluid with a selective affinity for IGF-II. FEBS Lett (1986) 0.94
Plasma lipotropin increase in man after growth hormone administration. Comparison between extractive and biosynthetic hormones. J Clin Endocrinol Metab (1983) 0.94
Growth of lung volumes during the first three years of life. Bull Eur Physiopathol Respir (1979) 0.94
Effects of exogenous insulin-like growth factor I on insulin-like growth factor binding proteins in a case of growth hormone insensitivity (Laron-type). Acta Paediatr Scand Suppl (1991) 0.93
Complete characterization of the human IGF-I nucleotide sequence isolated from a newly constructed adult liver cDNA library. FEBS Lett (1986) 0.92
On the nomenclature of the IGF binding proteins. Acta Endocrinol (Copenh) (1989) 0.92
Aryl hydrocarbon hydroxylase activity in human placenta of passive smokers. Environ Res (1989) 0.92
Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases. N Engl J Med (1979) 0.92
The new steroid analog RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab (1984) 0.92
Evaluation of diagnostic criteria for Leydig cell tumours in adult men revealed by gynaecomastia. Clin Endocrinol (Oxf) (1987) 0.91
Infraclavicular block with lateral approach and nerve stimulation: extent of anesthesia and adverse effects. Reg Anesth Pain Med (2002) 0.91
A French collaborative survey of 272 fetuses with 22q11.2 deletion: ultrasound findings, fetal autopsies and pregnancy outcomes. Prenat Diagn (2014) 0.91
Influence of thyroid status on hemoglobin A2 expression. J Clin Endocrinol Metab (1983) 0.90
[Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide]. Ann Endocrinol (Paris) (1968) 0.90
[Rheology of bronchial secretions and mucociliary transport (author's transl)]. Bull Eur Physiopathol Respir (1977) 0.90
Placental aryl hydrocarbon hydroxylase activity and placental calcifications. Toxicology (1992) 0.90
Somatomedin (insulin-like growth factors)-binding proteins. Molecular forms and regulation. Horm Res (1986) 0.89
Aryl hydrocarbon hydroxylase activity in human placenta and threatened preterm delivery. J Expo Anal Environ Epidemiol (1993) 0.89
Evidence for production by the liver of two IGF binding proteins with similar molecular weights but different affinities for IGF I and IGF II. Their relations with serum and cerebrospinal fluid IGF binding proteins. J Clin Endocrinol Metab (1982) 0.88
Growth hormone therapy with three dosage regimens in children with idiopathic short stature. European Study Group Participating Investigators. J Pediatr (1998) 0.88
[Isolated gonadotropic insufficiency revealing haemochromatosis (author's transl) (proceedings)]. Ann Endocrinol (Paris) (1977) 0.88
[Comparison of the individual deprivation index of the French Health Examination Centres and the administrative definition of deprivation]. Sante Publique (2006) 0.88
Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line. Exp Cell Res (1995) 0.87
The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects. J Clin Endocrinol Metab (1992) 0.87
Changes in blood leucocyte populations induced by acute maximal and chronic submaximal exercise. Eur J Appl Physiol Occup Physiol (1990) 0.87
Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome. J Clin Endocrinol Metab (1986) 0.87
Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J (2011) 0.87
Expression of insulin-like growth factor II (IGF-II) in human primary liver cancer: mRNA and protein analysis. J Hepatol (1990) 0.86
Long-term evaluation of motor function following intraneural injection of ropivacaine using walking track analysis in rats. Br J Anaesth (2005) 0.86
IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. Int J Cancer (1998) 0.86
Molecular diagnosis of Turner's syndrome. J Med Genet (1992) 0.86
Effect of physical exhaustion on cognitive functioning. Percept Mot Skills (1997) 0.86
Workplace bullying and psychotropic drug use: the mediating role of physical and mental health status. Ann Occup Hyg (2010) 0.86
Heterogeneity of insulin-like growth factor binding proteins between structure and affinity. 2. Forms released by human and rat liver in culture. Eur J Biochem (1987) 0.85
Determination of capillary oxygen tension in infants and children: assessment of methodology and normal values during growth. Bull Eur Physiopathol Respir (1979) 0.85
Mucociliary transport in vivo and in vitro. Relations to sputum properties in chronic bronchitis. Eur J Respir Dis (1980) 0.85
In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest (1994) 0.85
Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology (1994) 0.85
Expression and subcellular localization of dystrophin in skeletal, cardiac and smooth muscles during the human development. Neuromuscul Disord (1995) 0.85
Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22-25-kDa proteolytic fragment (1-160) and inhibited by the 16-kDa fragment (1-95) of recombinant human insulin-like growth factor binding protein-3. Growth Horm IGF Res (1998) 0.84
Isolation from human cerebrospinal fluid of a new insulin-like growth factor-binding protein with a selective affinity for IGF-II. FEBS Lett (1989) 0.84
The simultaneous assay of cortisol and 17alpha-hydroxyprogesterone in the plasma of patients with congenital adrenal hyperplasia. Acta Endocrinol (Copenh) (1973) 0.84
[Demonstration of an important production of carbon monoxide by sterile bacteriologic culture media]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.84
A new male pseudo-hermaphroditism associated with hypertension due to a block of 17 -hydroxylation. J Clin Endocrinol Metab (1972) 0.84
Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology (1994) 0.84
Insulin-like growth factor-I gene analysis in subjects with constitutionally variant stature. Pediatr Res (1990) 0.84
Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Growth Regul (1996) 0.84
Purified preparations of the amniotic fluid-derived insulin-like growth factor-binding protein contain multimeric forms that are biologically active. Endocrinology (1989) 0.83
Triiodothyronine stimulates the production of insulin-like growth factor (IGF) by fetal hypothalamus cells cultured in serum-free medium. Brain Res (1985) 0.83
Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. J Clin Endocrinol Metab (1988) 0.83
Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. J Clin Endocrinol Metab (1991) 0.83
[Cushing's syndrome. Medical treatment of adrenal hypercorticism]. Horm Res (1980) 0.83
Urinary free corticoids: an evaluation of their usefulness in the diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh) (1983) 0.83
Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy. J Clin Endocrinol Metab (1982) 0.83
[Factitious thyrotoxicosis]. Rev Fr Endocrinol Clin (1967) 0.83